Art A. Garcia - Feb 20, 2025 Form 4 Insider Report for RAYMOND JAMES FINANCIAL INC (RJF)

Role
Director
Signature
/s/ Art A. Garcia by Jonathan J. Doyle as Attorney-in-Fact
Stock symbol
RJF
Transactions as of
Feb 20, 2025
Transactions value $
$0
Form type
4
Date filed
2/24/2025, 04:32 PM
Previous filing
Jan 7, 2025
Next filing
Apr 2, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RJF Common Stock Options Exercise $0 +1.71K +62.79% $0.00 4.44K Feb 20, 2025 Direct F1
transaction RJF Common Stock Award $0 +1.25K +28.25% $0.00 5.69K Feb 20, 2025 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RJF Restricted Stock Units Options Exercise $0 -1.71K -100% $0.00 0 Feb 20, 2025 Common Stock 1.71K Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit (RSU) represents a contingent right to receive, upon vesting of the award: (i) one share of common stock, and (ii) accrued cash in lieu of dividends.
F2 Consists of a grant of Deferred Restricted Stock Units ("DRSUs") as part of compensation for service on the registrant's Board of Directors. Upon vesting, the DRSUs convert to the right to receive shares of common stock on a one-to-one basis, together with accrued cash in lieu of dividends. The DRSUs vest at the date of the next succeeding annual shareholders meeting following the grant date, but no later than March 15 of the calendar year following grant. Pursuant to an irrevocable election by the reporting person, settlement of the DRSUs will be deferred following vesting until the date the reporting person terminates his or her service on the Board of Directors.
F3 Includes DRSUs.
F4 The award vested in accordance with its terms, which provided for vesting at the date of the next succeeding annual shareholders meeting following the grant date, but no later than March 15 of the calendar year following grant.

Remarks:

This Form 4 reports (i) the acquisition by the reporting person of DRSUs resulting from an annual grant to the registrant's non-executive directors and (ii) the vesting of RSUs awarded to the reporting person.